Skip to content

Depression research published in 2014

Page 4 of 4: studies 61 to 65 of 65, newest first. Back to the depression overview

Studies

The Effect of Mindfulness-based Cognitive Therapy on Reduction of Depression and Dysfunctional Attitudes of Divorced Women

International Journal of Psychology and Psychiatry 2014 A. Zebarjadi, D. Ghasemian, R. Hassanzadeh

The present study was conducted on the effect of mindfulness-based cognitive therapy (MBCT) on reduction of depression and Dysfunctional attitudes of divorced women in Tehran. It was an experimental study with pre-test-post-test design and control group. The population consists (100) individuals who answered the depression and dysfunctional attitudes questionnaires and 20 samples were chosen...

Broadening horizons: Mindfulness-based cognitive therapy for older people experiencing depression

FPOP Bulletin: Psychology of Older People 2014 Peter Keohane

Mindfulness-based cognitive therapy (MBCT) is an integrative psychological approach linking mindful meditation with cognitive therapy. It has a strong evidence base in treating recurrent depression. However, limited research has been completed with older people. The present study evaluates one adapted, community based MBCT group (N=8) in a partial replication of Smith, Graham and Senthinathan...

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Frontiers in Pharmacology 2014 Petra Amchova, Jana Kučerová, Valentina Giugliano et al.

Depression has been associated with drug consumption, including heavy or problematic cannabis use. According to an animal model of depression and substance use disorder comorbidity, we combined the olfactory bulbectomy (OBX) model of depression with intravenous drug self-administration procedure to verify whether depressive-like rats displayed altered voluntary intake of the CB1 receptor...

Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Journal of Psychopharmacology January 2014 John Turner, Andrew C. Parrott, Julia Goodwin et al.

The recreational drug MDMA (3,4-methylenedioxymethamphetamine) or 'Ecstasy' is associated with heightened psychiatric distress and feelings of depression. The Drugs and Infancy Study (DAISY) monitored the psychiatric symptom profiles of mothers who used Ecstasy/MDMA while pregnant, and followed them over the first year post-partum. We compared 28 young women whom took MDMA during their...